Suppr超能文献

小肠局部区域神经内分泌肿瘤初次切除不充分后的手术再次干预结果

Results of Surgical Reintervention After Suboptimal Initial Resection for Locoregional Neuroendocrine Tumors of the Small Intestine.

作者信息

Bartsch Detlef K, Krasser-Gercke Norman, Jesinghaus Moritz, Görlach Jannis, Eilsberger Frederike, Rinke Anja, Maurer Elisabeth

机构信息

Department of Visceral-, Thoracic- and Vascular Surgery, Philipps-University Marburg, Marburg, Germany.

Institute of Pathology, Philipps-University Marburg, Marburg, Germany.

出版信息

World J Surg. 2025 May;49(5):1343-1350. doi: 10.1002/wjs.12582. Epub 2025 Apr 16.

Abstract

BACKGROUND

Complete resection is the only chance for cure in small intestine neuroendocrine neoplasms (SI-NEN). Previous ENETS guidelines proposed standards for the surgery of SI-NEN, which should be followed to provide long-term disease-free survival.

AIM

To analyze the results of reintervention for locoregional SI-NEN (stages I-III) after suboptimal initial resection.

METHODS

Perioperative characteristics of all patients who underwent surgical reintervention after suboptimal initial resection (SIR) of locoregional SI-NEN were retrieved from a prospective database. Patient characteristics, initial and redo procedures, imaging before reintervention, pathological results of SIR, and after reintervention, including missed primary tumors and lymph node metastases, were retrospectively analyzed.

RESULTS

During a 15 years period, 21 of 93 (22%) patients had surgical reinterventions after SIR. In 20 of 21 (95%) cases, the initial resection was performed outside an ENETS center of excellence. Ten (48%) of those cases were emergency operations because of the bowel obstruction or bowel bleeding. Seven SIR (33%) cases were performed laparoscopically, and in another 5 (24%) cases, a complete endoscopic mucosa resection was performed. Imaging before reintervention visualized residual disease in 15 of 21 (71%) patients. Surgical reintervention included either lymphadenectomy alone (LAD, n = 3) or small bowel resection plus systematic LAD (n = 12) or right hemicolectomy/ileocecal resection with systematic LAD (n = 6), respectively. In 19 of 21 (90%) patients, a R0 resection could be achieved. One patient (5%) experienced postoperative clinically relevant complications. According to pathology, in 10 (48%) patients lymph node metastases, in 6 (29%) patients additional primary tumors, and in 5 (24%) patients, both lymph nodes metastases and primary tumors were left behind in the SIR. After mean follow-up of 52 months, 16 (76%) of 21 patients were free of disease, 4 (19%) patients were alive with disease, and 1 patient deceased of an unrelated cause.

CONCLUSION

The proposed standards to resect locoregional SI-NEN should be followed to avoid SIR, although the prognosis after adequate surgical reintervention is good.

摘要

背景

完整切除是小肠神经内分泌肿瘤(SI-NEN)唯一的治愈机会。先前的欧洲神经内分泌肿瘤学会(ENETS)指南提出了SI-NEN的手术标准,应遵循这些标准以实现长期无病生存。

目的

分析局部区域SI-NEN(I-III期)初次切除不充分后再次干预的结果。

方法

从一个前瞻性数据库中检索所有在局部区域SI-NEN初次切除不充分(SIR)后接受手术再次干预的患者的围手术期特征。回顾性分析患者特征、初次和再次手术操作、再次干预前的影像学检查、SIR的病理结果以及再次干预后的病理结果,包括遗漏的原发性肿瘤和淋巴结转移情况。

结果

在15年期间,93例患者中有21例(22%)在SIR后接受了手术再次干预。在21例中的20例(95%)病例中,初次切除是在ENETS卓越中心以外进行的。其中10例(48%)病例是由于肠梗阻或肠出血而进行的急诊手术。7例SIR(33%)病例通过腹腔镜进行,另外5例(24%)病例进行了完整的内镜黏膜切除术。再次干预前的影像学检查显示21例患者中有15例(71%)存在残留病灶。手术再次干预分别包括单纯淋巴结清扫(LAD,n = 3)、小肠切除加系统性LAD(n = 12)或右半结肠切除/回盲部切除加系统性LAD(n = 6)。21例患者中有19例(90%)可实现R0切除。1例患者(5%)出现术后临床相关并发症。根据病理结果,10例(48%)患者有淋巴结转移,6例(29%)患者有额外的原发性肿瘤,5例(24%)患者在SIR中同时遗留了淋巴结转移和原发性肿瘤。平均随访52个月后,21例患者中有16例(76%)无疾病,4例(19%)患者带瘤生存,1例患者因无关原因死亡。

结论

应遵循提议的局部区域SI-NEN切除标准以避免SIR,尽管充分的手术再次干预后的预后良好。

相似文献

2
[Local resection of small intestine neuroendocrine neoplasms (SI-NEN) : Current principles].
Chirurgie (Heidelb). 2024 Oct;95(10):818-824. doi: 10.1007/s00104-024-02102-0. Epub 2024 May 21.
3
Prognostic Factors in Curative Resected Locoregional Small Intestine Neuroendocrine Neoplasms.
World J Surg. 2021 Apr;45(4):1109-1117. doi: 10.1007/s00268-020-05884-6. Epub 2021 Jan 8.
4
Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
J Neuroendocrinol. 2022 Jan;34(1):e13076. doi: 10.1111/jne.13076. Epub 2021 Dec 28.
8
Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center.
World J Surg. 2012 Jun;36(6):1419-31. doi: 10.1007/s00268-011-1296-z.
9
Surgical Treatment of NEN of Small Bowel: A Retrospective Analysis.
World J Surg. 2016 Mar;40(3):749-58. doi: 10.1007/s00268-016-3432-2.
10
Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S742-9. doi: 10.1245/s10434-015-4620-2. Epub 2015 May 27.

本文引用的文献

1
Isolated Tumor Cells Node Micro-metastasis in Early-Stage Small Intestinal Neuroendocrine Tumor.
Endocr Pathol. 2024 Sep;35(3):276-278. doi: 10.1007/s12022-024-09823-2. Epub 2024 Aug 22.
3
[Local resection of small intestine neuroendocrine neoplasms (SI-NEN) : Current principles].
Chirurgie (Heidelb). 2024 Oct;95(10):818-824. doi: 10.1007/s00104-024-02102-0. Epub 2024 May 21.
5
Vessel-Sparing Lymphadenectomy Should Be Performed in Small Intestine Neuroendocrine Neoplasms.
Cancers (Basel). 2022 Jul 25;14(15):3610. doi: 10.3390/cancers14153610.
6
Incidence and prognosis of patients with small intestinal neuroendocrine tumors in a population based nationwide study.
Cancer Epidemiol. 2022 Aug;79:102197. doi: 10.1016/j.canep.2022.102197. Epub 2022 Jun 16.
8
Predictors and Outcomes of Minimally Invasive Surgery for Small Bowel Neuroendocrine Tumors : Minimally Invasive Surgery for SBNETs.
J Gastrointest Surg. 2022 Jun;26(6):1252-1265. doi: 10.1007/s11605-022-05264-6. Epub 2022 Feb 7.
9
Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
J Neuroendocrinol. 2022 Jan;34(1):e13076. doi: 10.1111/jne.13076. Epub 2021 Dec 28.
10
International survey on opinions and use of minimally invasive surgery in small bowel neuroendocrine neoplasms.
Eur J Surg Oncol. 2022 Jun;48(6):1251-1257. doi: 10.1016/j.ejso.2021.11.011. Epub 2021 Nov 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验